Viewing Study NCT05584202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-03-08 @ 1:07 AM
Study NCT ID: NCT05584202
Status: TERMINATED
Last Update Posted: 2025-11-26
First Post: 2022-10-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants
Sponsor: ModernaTX, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None SARS-CoV-2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mRNA-1273 View
None mRNA-1273 vaccine View
None mRNA-1273.214 vaccine View
None mRNA-1273.214 View
None SARS-CoV-2 View
None SARS-CoV-2 Vaccine View
None Coronavirus View
None Virus Diseases View
None Messenger RNA View
None COVID 19 View
None COVID 19 Vaccine View
None Moderna View
None Bivalent omicron vaccine View
None Omicron vaccine View